Chargement en cours...
Emerging B-Cell Therapies in Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is a chronic, multisystem, autoimmune disease of unknown etiology, whose hallmark is the production of autoantibodies. B cells are promising targets for novel SLE therapies. In 2011, belimumab (Benlysta(®)), a fully humanized monoclonal antibody inhibiting B-cell a...
Enregistré dans:
| Publié dans: | Ther Clin Risk Manag |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove
2021
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7814238/ https://ncbi.nlm.nih.gov/pubmed/33488082 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S252592 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|